Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) (CAT#: CROSSAB-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) (CROSSAB-132). Click the button below to contact us or submit your feedback about this product.